Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cerabeta is a Canadian life sciences company focused on the development and commercialization of functional food ingredients derived from barley. The company's primary product is a highly concentrated barley beta-glucan, a soluble fiber recognized by health authorities for its ability to lower cholesterol and reduce the risk of heart disease. Cerabeta employs a proprietary, chemical-free extraction process that maintains the natural molecular weight and viscosity of the fibers, ensuring maximum biological efficacy. Their products are designed for integration into various food formats or as standalone nutritional supplements to support metabolic health and glycemic control. Based in Alberta, the company leverages regional agricultural expertise to produce non-GMO, clean-label health solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cerabeta.